OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interplay between the Cancer Genome and Epigenome
Hui Shen, Peter W. Laird
Cell (2013) Vol. 153, Iss. 1, pp. 38-55
Open Access | Times Cited: 848

Showing 1-25 of 848 citing articles:

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan, Paul T. Spellman, Christopher J. Ricketts, et al.
New England Journal of Medicine (2015) Vol. 374, Iss. 2, pp. 135-145
Open Access | Times Cited: 1180

Epigenetic plasticity and the hallmarks of cancer
William Flavahan, Elizabeth Gaskell, B Bernstein
Science (2017) Vol. 357, Iss. 6348
Open Access | Times Cited: 1150

Epigenetic Determinants of Cancer
Stephen B. Baylin, Peter A. Jones
Cold Spring Harbor Perspectives in Biology (2016) Vol. 8, Iss. 9, pp. a019505-a019505
Open Access | Times Cited: 1078

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng, He Cai, Manni Wang, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 891

Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B. Baylin
Molecular Cell (2014) Vol. 54, Iss. 5, pp. 716-727
Open Access | Times Cited: 858

Histone Modifications and Cancer
James E. Audia, Robert M. Campbell
Cold Spring Harbor Perspectives in Biology (2016) Vol. 8, Iss. 4, pp. a019521-a019521
Open Access | Times Cited: 829

Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Andrew P. Feinberg, Michael A. Koldobskiy, Anita Göndör
Nature Reviews Genetics (2016) Vol. 17, Iss. 5, pp. 284-299
Open Access | Times Cited: 765

The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb Davis, Christopher J. Ricketts, Min Wang, et al.
Cancer Cell (2014) Vol. 26, Iss. 3, pp. 319-330
Open Access | Times Cited: 763

Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes
Wanding Zhou, Peter W. Laird, Hui Shen
Nucleic Acids Research (2016), pp. gkw967-gkw967
Open Access | Times Cited: 743

DNA Methylation in Cancer and Aging
Michael Klutstein, Deborah Nejman, Razi Greenfield, et al.
Cancer Research (2016) Vol. 76, Iss. 12, pp. 3446-3450
Closed Access | Times Cited: 737

Genetic landscape of esophageal squamous cell carcinoma
Yibo Gao, Zhao-Li Chen, Jia-Gen Li, et al.
Nature Genetics (2014) Vol. 46, Iss. 10, pp. 1097-1102
Closed Access | Times Cited: 646

Metastatic Stem Cells: Sources, Niches, and Vital Pathways
Thórdur Óskarsson, Eduard Batlle, Joan Massagué
Cell stem cell (2014) Vol. 14, Iss. 3, pp. 306-321
Open Access | Times Cited: 645

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A. Northcott, Catherine Lee, Thomas Zichner, et al.
Nature (2014) Vol. 511, Iss. 7510, pp. 428-434
Open Access | Times Cited: 606

Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm, Sebastian Bender, David Jones, et al.
Nature reviews. Cancer (2014) Vol. 14, Iss. 2, pp. 92-107
Open Access | Times Cited: 526

Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
Joyce V. Lee, Alessandro Carrer, Supriya Shah, et al.
Cell Metabolism (2014) Vol. 20, Iss. 2, pp. 306-319
Open Access | Times Cited: 514

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi, Taha Merghoub, Jedd D. Wolchok
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 581-598
Open Access | Times Cited: 468

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard, S. Shulman, Diana Farhat, et al.
Drug Resistance Updates (2018) Vol. 38, pp. 1-11
Closed Access | Times Cited: 464

Epigenetic modifications of histones in cancer
Zibo Zhao, Ali Shilatifard
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 448

Heterochromatin: Guardian of the Genome
Aniek Janssen, Serafin U. Colmenares, Gary H. Karpen
Annual Review of Cell and Developmental Biology (2018) Vol. 34, Iss. 1, pp. 265-288
Open Access | Times Cited: 427

Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing
Volker Hovestadt, David Jones, Simone Picelli, et al.
Nature (2014) Vol. 510, Iss. 7506, pp. 537-541
Closed Access | Times Cited: 423

Cancer epigenetics: Moving forward
Angela Nebbioso, Francesco Paolo Tambaro, Carmela Dell’Aversana, et al.
PLoS Genetics (2018) Vol. 14, Iss. 6, pp. e1007362-e1007362
Open Access | Times Cited: 416

Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
Christoph Plass, Stefan M. Pfister, Anders M. Lindroth, et al.
Nature Reviews Genetics (2013) Vol. 14, Iss. 11, pp. 765-780
Closed Access | Times Cited: 415

SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions
Wanding Zhou, Timothy J. Triche, Peter W. Laird, et al.
Nucleic Acids Research (2018)
Open Access | Times Cited: 409

Clinical implications of intratumor heterogeneity: challenges and opportunities
Santiago Ramón y Cajal, Marta Sesé, Claudia Capdevila, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 2, pp. 161-177
Open Access | Times Cited: 388

Page 1 - Next Page

Scroll to top